Neovasc Inc
TSX:NVCN

Watchlist Manager
Neovasc Inc Logo
Neovasc Inc
TSX:NVCN
Watchlist
Price: 40.15 CAD Market Closed
Market Cap: 110.8m CAD

Relative Value

There is not enough data to reliably calculate the relative value of NVCN.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NVCN Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
21.2
Median 5Y
21.3
Industry
2.3
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2
Industry
22.1
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-3.2
Industry
14.3
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-3.1
Industry
20.2
vs History
vs Industry
Median 3Y
5.1
Median 5Y
5
Industry
2.2
vs History
vs Industry
Median 3Y
17.7
Median 5Y
17.7
Industry
2.5
vs History
vs Industry
Median 3Y
22.3
Median 5Y
22.3
Industry
5.1
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.1
Industry
11.7
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2
Industry
16.1
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.7
Industry
14.4
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.7
Industry
18.1
vs History
vs Industry
Median 3Y
6.3
Median 5Y
6.3
Industry
1.9

Multiples Across Competitors

NVCN Competitors Multiples
Neovasc Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Neovasc Inc
TSX:NVCN
110.5m CAD 21.2 -2 -2.1 -2
US
Abbott Laboratories
NYSE:ABT
219.8B USD 5.1 15.7 20.8 29.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
177B USD 19.4 67.9 52.9 63.6
US
Boston Scientific Corp
NYSE:BSX
156.6B USD 8.5 62.5 35.1 48.3
US
Stryker Corp
NYSE:SYK
153.1B USD 6.6 53.6 26.4 31.8
IE
Medtronic PLC
NYSE:MDT
117.9B USD 3.5 25.3 14.1 20
DE
Siemens Healthineers AG
XETRA:SHL
53.7B EUR 2.3 25.7 14.4 19.9
US
Becton Dickinson and Co
NYSE:BDX
52.4B USD 2.5 34.5 13.6 25.5
US
Edwards Lifesciences Corp
NYSE:EW
46B USD 8.1 11.1 24.5 26.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.7B USD 11.6 51.1 36.2 40.4
US
Resmed Inc
NYSE:RMD
40.2B USD 8 30.6 21.8 24.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Neovasc Inc
TSX:NVCN
Average EV/EBITDA: 26
Negative Multiple: -2.1
N/A N/A
US
Abbott Laboratories
NYSE:ABT
20.8
13%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
52.9
24%
2.2
US
Boston Scientific Corp
NYSE:BSX
35.1
21%
1.7
US
Stryker Corp
NYSE:SYK
26.4
12%
2.2
IE
Medtronic PLC
NYSE:MDT
14.1
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
14.4
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.6
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
24.5
12%
2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
36.2
12%
3
US
Resmed Inc
NYSE:RMD
21.8
12%
1.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Neovasc Inc
TSX:NVCN
Average EV/EBIT: 33.1
Negative Multiple: -2
N/A N/A
US
Abbott Laboratories
NYSE:ABT
29.3
22%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
63.6
26%
2.4
US
Boston Scientific Corp
NYSE:BSX
48.3
31%
1.6
US
Stryker Corp
NYSE:SYK
31.8
16%
2
IE
Medtronic PLC
NYSE:MDT
20
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.9
19%
1
US
Becton Dickinson and Co
NYSE:BDX
25.5
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
26.9
12%
2.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
40.4
12%
3.4
US
Resmed Inc
NYSE:RMD
24.8
14%
1.8